|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vascular access and closure in coronary angiography and percutaneous intervention 显示文摘 | Byrne RA Cassese S Linhardt M | 2013 | Nat RevCardiol2013，10，1： | 1 |
| 2 | The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders显示文摘 | Bernlochner I Byrne RA Kastrati A | 2011 | Expert Rev Cardiovasc Ther2011，9，8： | 1 |
| 3 | Drug-eluting stents in percutaneous coronary intervention:a benefit-risk assessment显示文摘 | Byrne RA Sarafoff N Kastrati A | 2009 | Drug Saf2009，32，9： | 1 |
| 4 | Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts显示文摘 | Byrne JA Nguyen HN Reijo Pera RA | 2009 | PLoS One2009，4，9： | 1 |
| 5 | Drug-eluting stents versus baremetal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials 显示文摘 | Iijima R Byrne RA Dibra A | 2009 | Rev Esp Cardiol2009，62，4： | 1 |
| 6 | Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis显示文摘 | Joner M Radke PW Byrne RA | 2013 | J Biomater Appl2013，27，6： | 1 |
| 7 | Incidence and predictors of rest- enosis after coronary stenting in 10 004 patients with surveillance an- giography 显示文摘 | Cassese S Byrne RA Tada T | 2014 | Heart2014，100，： | 1 |
| 8 | Biodegradable polymer versus permanent polymer drug-eluting stents ande- verolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical triM显示文摘 | Byrne RA Kastrati A Massberg S | 2011 | J Am Coil Cardiol2011，58，13： | 1 |
| 9 | Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with rest- enosis after implantation of a drug-eluting stent ( ISAR-DESIRE 3 ) : a randomised, open-label trial 显示文摘 | Byrne RA Neumann FJ Mehilli JA | 2013 | Lancet2013，381，9865： | 1 |
| 10 | Randomized,non-inferiority trial of three limus agent-eluting stents with different polymer coatings:the Intracoronary Stenting and Angiographic Results:Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial显示文摘 | Byrne RA Kastrati A Kufner S | 2009 | Eur Heart J2009，30，20： | 1 |
| 11 | Randomized trial of paclitaxel versus simIimus-elutlng stents for treatment of coronary restenosis in simlimus-eluting stems: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographie Results: Drug Eluting Stents for In-Stent Restenosis 2)study显示文摘 | Mehilli J Byrne RA Tin:oh K | 2010 | J Am Coll Cardiol2010，55，： | 1 |
| 12 | Current treatment of In-Stent restenosis显示文摘 | Alfonso F Byrne RA Rivero FA | 2014 | J Am Coll Cardiol2014，63，24： | 1 |
| 13 | Preclinical profile of VX-950,a potent,selective,and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease显示文摘 | Perni RB Almquist SJ Byrn RA | 2006 | Antimicrob Agents Chemother2006，50，3： | 1 |
| 14 | Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis:2-year follow-up results显示文摘 | Byrne RA Kufner S Tiroch K | 2009 | Heart2009，95，18： | 1 |
| 15 | Current treatment of in-stent restenosis显示文摘 | Alfonso F Byrne RA Rivero F | 2014 | J Am Coll Cardiol2014，63，24： | 1 |
| 16 | Paclitaxel-eluting balloons, paclitaxel-eluting stents , and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial显示文摘 | Byrne RA Neumann FJ Mehilli J | 2013 | Lancet2013，381，9865： | 1 |
| 17 | Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 ( Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2 ) study 显示文摘 | Mehilli J Byrne RA Tiroch K | 2010 | Journal of the American College of Cardiology2010，55，24： | 1 |
| 18 | Biodegradable polymer drug-elu- ring stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trims 显示文摘 | Stefanini GG Byrne RA Serruys PW | 2012 | Eur Heart J2012，33，10： | 1 |
| 19 | Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with rest- enosis after implantation of a drug-eluting stent ( ISAR-DESIRE 3 ) : a randomised, open-label trial 显示文摘 | Byrne RA Neumann FJ Mehilli JA | 2013 | Lancet2013，381，9865： | 1 |
| 20 | Differential relative efficacy between drug-eluting stents in patients with bare metal and drug- eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials显示文摘 | Byrne RA Cassese S Windisch T | 2013 | Eurolntervention2013，9，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员